Objective:To investigate the incidence of sarcopenia in elderly people with chronic comorbidities, and to explore their relationships. Methods:A total of 1 026 elderly patients with chronic comorbidities were selected from the physical examination center of our hospital from January 2018 to December 2020. Sarcopenia was diagnosed according to the diagnostic criteria of Asian Working Group for Sarcopenia in 2014. Logistic regression was used to analyze the relationship between sarcopenia and chronic comorbidities. Results:Among 1 026 elderly patients with chronic comorbidities, 347(33.82%) had sarcopenia. There were 390 cases(38.01%) with only 2 chronic diseases, 387 cases(37.72%) with only 3 kinds of chronic diseases, and 249 cases(24.27%) with 4 or more chronic diseases. In patients with 2, 3, 4 or more kinds of chronic comorbidities, sarcopenia respectively accounted for 15.90%(62/390), 31.78%(123/387), 65.06%(162/387). The difference was statistically significant(P<0.001).The variety of chronic comorbidities, diabetes mellitus, chronic obstructive pulmonary disease, chronic kidney disease and chronic gastrointestinal disease which entered the regression equation were undergone difference analysis. Conclusion:Sarcopenia is common in elderly patients with chronic comorbidities. The more comorbidities, the higher the incidence of sarcopenia is. The variety of comorbidities, diabetes mellitus, chronic obstructive pulmonary disease, chronic kidney disease and chronic gastrointestinal disease may be related to the occurrence of sarcopenia in elderly patients with chronic comorbidities. |
[1] 张新卉,谷雨萌,王仲言,等. 三甲医院和社区医院老年慢性病共病现状调查[J].临床荟萃,2021,36(1):39-43.
[2] 唐聪,李檬妤,王斌,等. 武汉市老年人慢性病患病现状及知信行调查[J].中国老年学杂志,2017,37(5):1231-1234.
[3] 闫伟,路云,张冉,等. 基于CHARLS数据分析的我国老年人共病现状研究[J].中华疾病控制杂志,2019,23(4):426-430.
[4] NCD Countdown 2030 collaborators.NCD Countdown 2030:worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4[J].Lancet, 2018,392(10152):1072-1088.
[5] CHEN L K, LEE W J, PENG L N, et al. Recent advances in sarcopenia research in Asia:2016 update from the Asian Working Group for sarcopenia[J].J Am Med Dir Assoc, 2016, 17(8):767.
[6] WARD B W,BLACK L I.State and regional prevalence of diagnosed multiple chronic conditions among adults aged ≥ 18 years-United States,2014[J].MMWR Morb Mortal Wkly Rep,2016,65(29):735-738
[7] GU J Y,CHAO J Q,CHEN W J,et al.Multimorbidity in the community-dwelling elderly in urban China[J].Arch Gerontol Geriatr,2017,68:62-67.
[8] 陈静,刘海燕,李建中,等. 老年住院病人慢性病共病模式分析[J].实用老年医学,2018,32(8):766-769.
[9] 狄娜,郑嘉堂,王鹏飞,等. 北京市老年人慢性病及共病分析[J].中国全科医学,2018,21(3):265-268.
[10] 闫巍,李瑞,王杰萍,等. 北京市某三级医院综合科老年共病住院患者临床特点分析[J].中国全科医学,2018,21(14):1648-1656.
[11] 马珂,冯玫,赵瑞敏,等.全科医学科住院患者共病情况调查研究[J].中国全科医学,2017,20(23):2820-2822.
[12] 张晗,齐士格,李志新,等.2015年六省市社区老年人常见慢性病共病现状[J].首都公共卫生,2019, 13(3):122-125.
[13] 陈建,杨晓虹,曾莉萍,等. 成都新都区社区居民老年慢性病患病现状及其患共病模式分析[J].中国卫生事业管理,2018,35(8):573-575,615.
[14] 金丹. 慢性病及共病的研究进展[J].锦州医科大学学报,2019,40(1):109-112.
[15] 吴兴利,周长喜,施伟伟,等. 老年肌少症与常见慢病共病的研究进展[J].老年医学与保健,2020,26(1):154-158.
[16] 李梅, 胡亦新, 董宏艳, 等. 采用不同标准对北京社区男性老年肌少症检出率比较的研究[J].中华保健医学杂志, 2014, 16(6):426-429.
[17] FOLEY R N, WANG C, ISHANI A, et al. Kidney function and sarcopenia in the United States general population:NHANES III[J].Am J Nephrol, 2007, 27(3):279-286.
[18] ORNSTEIN S M,NIETER P J,JENKINS R G,et al. The prevalence of chronic diseases and multimorbidity in primary care practice:a PPRnet report[J].Am Board Fam Med,2013,26(5):518-524.
[19] 刘钟桧,张晓琳,刘新民. 肌肉减少症与慢性阻塞性肺疾病关系的研究进展[J].中华老年医学杂志,2019,38(8):945-948.
[20] CESARI M, KRITCHEVSKY S B, BAUMGARTNER R N. Sarcopenia, obesity, and inflammation-results from the trial of angiotensin converting enzyme inhibition and novel cardiovascular risk factors study[J].Am J Clin Nutr, 2005, 82(2):428-434. |
